Abstract
By rapidly establishing reperfusion, percutaneous transluminal coronary angioplasty (PTCA) can have a beneficial effect in patients with cardiogenic shock. In several series, PTCA was associated with survival to hospital discharge of approximately 60%. Unresolved issues relate to the management of patients with multivessel disease, the role of concomitant thrombolytic therapy, and the use of mechanical support devices.
Original language | English (US) |
---|---|
Pages (from-to) | 36-38+44+46+51 |
Journal | Primary Cardiology |
Volume | 18 |
Issue number | 7 |
State | Published - Jan 1 1992 |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine